These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22140017)

  • 1. Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape.
    Daum N; Tscheka C; Neumeyer A; Schneider M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(1):52-65. PubMed ID: 22140017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine.
    Elizondo E; Moreno E; Cabrera I; Córdoba A; Sala S; Veciana J; Ventosa N
    Prog Mol Biol Transl Sci; 2011; 104():1-52. PubMed ID: 22093216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 4. New carbon materials: biological applications of functionalized nanodiamond materials.
    Krueger A
    Chemistry; 2008; 14(5):1382-90. PubMed ID: 18033700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
    Muthu MS; Singh S
    Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy.
    Lee SH; Heng D; Ng WK; Chan HK; Tan RB
    Int J Pharm; 2011 Jan; 403(1-2):192-200. PubMed ID: 20951781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments.
    Krol S; Ellis-Behnke R; Marchetti P
    Nanomedicine; 2012 Sep; 8 Suppl 1():S69-76. PubMed ID: 22640905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles for drug delivery to the lungs.
    Sung JC; Pulliam BL; Edwards DA
    Trends Biotechnol; 2007 Dec; 25(12):563-70. PubMed ID: 17997181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of nanoparticles with immunocompetent cells: nanosafety considerations.
    Boraschi D; Costantino L; Italiani P
    Nanomedicine (Lond); 2012 Jan; 7(1):121-31. PubMed ID: 22191781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
    Merisko-Liversidge E; Liversidge GG
    Adv Drug Deliv Rev; 2011 May; 63(6):427-40. PubMed ID: 21223990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.
    Rothenfluh DA; Hubbell JA
    Integr Biol (Camb); 2009 Jul; 1(7):446-51. PubMed ID: 20023754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of solid nanoparticles for drug delivery.
    Arayne MS; Sultana N; Noor-Us-Sabah
    Pak J Pharm Sci; 2007 Jul; 20(3):251-9. PubMed ID: 17545113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
    Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
    Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shape-specific polymeric nanomedicine: emerging opportunities and challenges.
    Tao L; Hu W; Liu Y; Huang G; Sumer BD; Gao J
    Exp Biol Med (Maywood); 2011 Jan; 236(1):20-9. PubMed ID: 21239732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.